Cowen Starts Biodesix (BDSX) at Outperform

April 20, 2022 5:36 AM EDT Send to a Friend
Cowen analyst Max Masucci initiates coverage on Biodesix (NASDAQ: BDSX) with an Outperform rating.The analyst commented, "We initiate coverage ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login